Alnylam sues Pfizer and Moderna | ABUS Message Board Posts


Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  35161 of 35171  at  3/17/2022 8:41:22 AM  by

Steve_382


Alnylam sues Pfizer and Moderna

Interesting.
 

Alnylam Pharmaceuticals Files Patent Infringement Suits against Pfizer and Moderna

Mar 17, 2022

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 17, 2022--

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) the leading RNAi therapeutics company, announced today that it has separately filed suit in United States District Court for the District of Delaware against Pfizer, Inc. and Moderna, Inc., seeking damages for infringement of U.S. Patent No. 11,246,933 (the “’933 Patent”) in the parties’ manufacture and sale of their messenger RNA (mRNA) COVID-19 vaccines. The patent relates to Alnylam’s biodegradable cationic lipids that are foundational to the success of the mRNA COVID-19 vaccines. The complaints can be accessed on Alnylam’s website (Pfizer and Moderna).

Alnylam is seeking fair compensation for use of its technology based on patent claims to a broad class of biodegradable lipids invented over a decade ago resulting from extensive research and investment. The Company is proud that this work has supported rapid development of the life-saving vaccines. Alnylam does not intend to seek an injunction or take action that impedes production, sale or distribution of the vaccines.

 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
35162 Re: Alnylam sues Pfizer and Moderna egomaniakos 5 3/17/2022 9:34:45 AM




Financial Market Data provided by
.
Loading...